Company / Revenue
Century Therapeutics, Inc. Revenue History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$6.6M
FY2025
5-year range
$2.2M / $6.6M
FY2022-FY2025
Trend
+194.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $5M to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2025 with a 3-year CAGR of +8.2%.
Improved from $5M to $7M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +8.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +8.2%, indicating consistent growth.
- In FY2025, revenue increased 194.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.6M | +194.8% |
| FY2024 | $2.2M | -57.0% |
| FY2023 | $5.2M | +0.0% |
| FY2022 | $5.2M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026